À proposConditionsConfidentialitéContact
 
Actualisation
CannMed Coffee Talk

CannMed Coffee Talk

Date de sortie : 2025-02-19
CannMed Coffee Talk - QR Code
118 épisodes
Audio
Écouter sur Apple Podcasts
118 épisodes
Audio
Écouter sur Apple Podcasts
Date de sortie : 2025-02-19
L’épisode le plus récent
Examining Long-Term Effects of Medical Cannabis with Staci Gruber, PhD

Examining Long-Term Effects of Medical Cannabis with Staci Gruber, PhD

Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber launched Marijuana Investigations for Neurosc
Durée : 46:34
Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School.
Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery (MIND) in 2014, the first ever program of its kind designed to clarify the long-term impact of medical cannabis use. MIND supports numerous projects that aim to address the impact of medical cannabis on a number of important variables including cognition, brain structure and function, clinical state, quality of life, pain, sleep, and other health-related measures. As director of MIND, Dr. Gruber has generated major contributions to the field as the first to assess medical cannabis patients longitudinally, first to acquire neuroimaging data in medical cannabis patients, and as Principal Investigator of the first clinical trial of a full-spectrum, high-cannabidiol (CBD) product, which she specifically formulated to treat anxiety. Additional, novel clinical trials have been approved and are pending or currently underway.
At CannMed 25 Staci will share findings from those clinical trials as an oral presenter. https://cannmedevents.com/staci-gruber-phd/
Topics Discussed:
Key findings from the MIND Program’s longitudinal studies on medical cannabis use (improved cognitive performance and reductions in pain, anxiety, and sleep disturbances)
Ongoing clinical trials the MIND Program is conducting on anxiety, bipolar disorder, and Alzheimer’s
The Women’s Health Initiative at MIND (WHIM) investigating cannabis for gynecologic pain, menopause, and endometriosis
Concerns about mislabeled cannabis products and unregulated hemp-derived products
and more!
Thanks to This Episode's Sponsor: Healer
Healer is a trusted, physician-developed medicinal cannabis brand founded to address the challenges of helping people and health providers get the best results with safe, reliably dosable products and education on how to best use them. Healer Hemp products are available nationwide and include a step-by-step usage guide and response tracker. Healer’s distinctive product formulations and education are based on the latest research and work of leading cannabis clinician, Dr. Dustin Sulak, D.O.
Visit Healer.com or HealerCbd.com
Additional Resources
https://www.drstacigruber.com
Social Media: @DrStaciGruber on X and Instagram
Register for CannMed 25
Meet the CannMed 25 Speakers
Review the Podcast
CannMed Archive
Id. d’épisode : 1000694002795
GUID : https://cannmedevents.com/?p=12355
Date de publication : 19/2/2025 à 13:44:08

Description

Brought to you by Medicinal Genomics

Apple Podcasts : Avis des utilisateurs

Pas d'entrée